Join Communities

Search Notes Gallery

Home / B.Pharm 1st Semester Notes / Introduction to Pharmacognosy Unit 5 Notes – Phyto-therapeutic Agents

Introduction to Pharmacognosy Unit 5 Notes – Phyto-therapeutic Agents

NotesGallery
Nov 19, 2026 • 35 min read
Introduction To Pharmacognosy Source: NotesGallery

Course Code: BP105T

Unit V Introduction

Phyto-therapeutic Agents. Medicinal plants supply crude drugs, extracts and chemically defined constituents. This unit connects the botanical identity of 19 drugs with their medicinal parts, major constituents and uses. A correct answer identifies the plant and organ before explaining its pharmacological importance.

Topics Covered – Syllabus Coverage

Required topic Coverage
Adaptogens and immunomodulators: Ashwagandha, Tulsi 5.3-5.4
Hepatoprotectives: Milk thistle, Kutki 5.5-5.6
Cardiovascular drugs: Garlic, Arjuna 5.7-5.8
Antidiabetics: Gymnema, Fenugreek 5.9-5.10
Anti-inflammatory and analgesics: Turmeric, Boswellia 5.11-5.12
CNS drug: Brahmi 5.13
Antimicrobial and antivirals: Giloy, Neem, Andrographis 5.14-5.16
Gastrointestinal drug: Psyllium 5.17
Dermatological agent: Aloe 5.18
Women’s health: Chasteberry, Shatavari 5.19-5.20
Respiratory drug: Vasaka 5.21
Comparisons, quality, revision and examination practice 5.22-5.25

Learning outcomes

  • State the biological source, family and medicinal part of every listed drug.
  • Recognise diagnostic features of leaves, roots, rhizomes, fruits, seeds, bark and resin.
  • Match each drug with its major constituent class and examples.
  • Explain its syllabus use and the limits of that use.
  • Distinguish similar names, different medicinal organs and different preparations.

Essential terms

Term Meaning
Phytotherapy Medicinal use of suitable plant preparations
Adaptogen Term used for agents studied for support of stress adaptation
Immunomodulator Agent that modifies an immune response
Hepatoprotective Describes protection against liver injury in a specified context
Marker Constituent measured for identity or consistency
Crude drug Relatively unrefined medicinal natural material
Extract Preparation obtained by solvent extraction

The guiding question

Why can two products bearing the same plant name differ in composition, activity and quality?

Answer: The species, organ, extraction method and standardisation determine what the preparation actually contains.

5.1 Phytotherapy: basic concepts

A phyto-therapeutic agent is a medicinal plant material, preparation or constituent used for a therapeutic purpose.

Pharmacognosy establishes its identity, composition and quality.

Phytotherapy applies suitable preparations; the activity of an isolated compound cannot automatically be assigned to every crude drug containing it.

Three levels of material

  • Crude drug: a defined plant organ, such as Ashwagandha root or Arjuna bark.
  • Preparation: powder, oil, gel or extract made from an authenticated organ by a stated method.
  • Constituent: a chemically defined substance or measured group, such as curcumin or silymarin.

Reading a medicinal claim

Traditional use describes a history of application.

Preclinical activity comes from laboratory or animal experiments.

Clinical evidence concerns studies in humans using particular preparations and outcomes.

These are different levels of evidence. An antimicrobial effect in a test tube does not establish treatment of an infection in a patient.

Why preparations differ

Water, alcohol and other suitable extraction systems recover different proportions of constituents.

Harvesting stage, drying, storage and processing can change composition.

Standardisation controls selected specifications; it does not make every extract chemically identical or prove clinical efficacy by itself.

Examination principle: Write the syllabus category, then the source, family, part, constituents and uses. Describe traditional or experimental activity accurately without turning it into a guaranteed cure.

5.2 Therapeutic groups and study method

The syllabus places plants in ten groups according to their principal teaching use. Many plants have additional reported activities, so this grouping is not an exclusive chemical classification.

Group Main idea
Adaptogens/immunomodulators Stress adaptation and modulation of immune responses
Hepatoprotectives Liver-related traditional use or studied protection
Cardiovascular agents Heart, blood pressure or lipid-related applications
Antidiabetics Glucose-related adjunctive or investigated effects
Anti-inflammatory/analgesic Inflammation and pain-related applications
CNS agents Cognition and nervous-system-related applications
Antimicrobial/antiviral Activity against microbes or viruses in a specified setting
Gastrointestinal Bowel function and digestive applications
Dermatological Skin-related applications
Women’s health/respiratory Reproductive-health or airway-related applications

A repeatable drug profile

  • Step 1: learn the scientific name and family.
  • Step 2: identify the medicinal organ.
  • Step 3: connect the organ with diagnostic features.
  • Step 4: name the constituent class and major examples.
  • Step 5: explain the use with an appropriate mechanism and evidence qualification.

Biological source versus geographical source

Biological source specifies the organism and medicinal material.

Geographical source concerns where it grows or is collected.

The phrase “an Indian herb” cannot replace a botanical name and part.

Older family names may occur in examinations; both older and current placement are identified where useful.

5.3 Ashwagandha: adaptogen and immunomodulator

Biological source and family

Ashwagandha consists principally of dried roots of Withania somnifera (L.) Dunal, family Solanaceae.

The name Indian ginseng does not mean that it belongs to the genus Panax.

Root preparations and leaf preparations have different chemical profiles.

Identification

The plant is a branching shrub with simple ovate leaves and berries enclosed by an enlarged persistent calyx.

The medicinal root is cylindrical, tapering and pale buff to yellowish brown, with longitudinal wrinkles and occasional lateral-root scars.

The interior is pale; organ identity should be confirmed rather than inferred from powder colour.

Ashwagandha shoot with ovate leaves and persistent calyces enclosing berries. The medicinal root is distinguished from these aerial organs in the drug profile.

Diagram labels: Ovate blade; persistent calyx; leaf stalk; berry in calyx.

Major constituents

Withanolides are steroidal lactones; withanolide A and related compounds are important examples.

Withanosides are glycosidic constituents.

Withaferin A occurs in the plant, but its proportion varies by organ and preparation; root material is not chemically interchangeable with leaves.

Uses and pharmacological basis

Ashwagandha is a traditional rasayana, used as a restorative and for stress-related complaints.

Some specific extracts have been studied for stress and sleep outcomes.

Effects on stress-response pathways and immune signalling have been investigated experimentally.

“Adaptogenic” and “immunomodulatory” describe the teaching context; they do not establish universal benefit or simply mean stimulation of all immunity.

Quality and relevant precautions

Root identity, extract specifications and withanolide profile matter.

Substitution of leaves for the specified root can change composition.

Sedation, medicine interactions and reported liver injury are relevant product concerns; pregnancy is a setting in which use is avoided.

Do not portray a root powder as equivalent to every extract used in a trial.

Memory key: Ashwagandha = root + Solanaceae + withanolides + stress-adaptation use.

5.4 Tulsi: adaptogen and immunomodulator

Biological source and family

Tulsi or holy basil is obtained from leaves and suitable aerial parts of Ocimum tenuiflorum L., synonym Ocimum sanctum L., family Lamiaceae.

The medicinal specification should state whether leaves alone or aerial material is required.

Identification

Tulsi is an aromatic herb or undershrub.

Leaves are opposite, petiolate, ovate and usually toothed.

The stem is commonly quadrangular and hairy.

Small flowers occur in whorled arrangements along terminal inflorescences.

Green and purplish forms exist; colour alone is not a reliable identity test.

Major constituents

The volatile oil may contain eugenol, with other terpenoid constituents varying by chemotype.

Ursolic acid, rosmarinic acid and other phenolics contribute to the broader chemical profile.

Essential oil represents the volatile fraction; it does not contain the complete composition of a leaf extract.

Uses and pharmacological basis

Tulsi is traditionally used for stress support and respiratory or digestive complaints.

Adaptogenic and immunomodulatory activities are investigated largely through experimental studies, with clinical evidence varying by preparation and outcome.

Antioxidant or immune effects measured in a laboratory do not establish prevention or cure of a viral disease.

Quality and preparation points

Aromatic identity, absence of foreign matter, leaf morphology and a suitable chromatographic profile support quality assessment.

Prolonged unsuitable heating or storage can lose volatile material.

Essential oil, fresh leaves and a dried aqueous extract should be described separately.

The preparation and intended route determine relevant safety considerations.

Tulsi flowering shoot. Opposite leaves with toothed margins and flower whorls along the terminal inflorescence are diagnostic features.

Diagram labels: Flower whorls; terminal spike; opposite leaves; toothed margin.

Memory key: Tulsi = opposite aromatic leaves + Lamiaceae + eugenol/phenolics. It shares a syllabus category with Ashwagandha, but not its organ or constituent class.

5.5 Milk thistle: hepatoprotective agent

Biological source and family

Milk thistle consists of ripe fruits of Silybum marianum (L.) Gaertn., family Asteraceae.

The fruit is a cypsela, often casually called a seed.

The medicinal fruit material is commonly freed from the pappus.

Identification

The plant has spiny, lobed leaves with characteristic pale marbling and purple flower heads.

The drug fruits are elongated, somewhat compressed, smooth and brownish, with variable darker markings.

A flower head or leaf is not a substitute for the specified fruit drug.

Milk thistle has spiny bracts and pale-marbled leaves. The enlarged fruit with its pappus is shown at lower right; commercial fruit material is commonly freed from the pappus.

Diagram labels: Spiny bracts; flower head; marbled leaf; fruit and pappus.

Major constituents

Silymarin is a mixture of flavonolignans, including silybin, isosilybin, silychristin and silydianin.

Silybin, also called silibinin in relevant chemical contexts, is a major component.

The fruits also contain fixed oil.

Silymarin is neither one pure molecule nor a secretion of milk.

Uses and pharmacological basis

Milk thistle preparations are used in liver-related herbal practice.

Antioxidant and membrane-related effects have been studied; evidence for clinical benefit differs by disease and product.

The broad word “hepatoprotective” must not be interpreted as reliable treatment of every liver disorder.

Specific medicinal preparations of silibinin have specialist applications distinct from ordinary supplements.

Quality and preparation points

Fruit identity, silymarin content and component profile are important.

Extraction conditions influence flavonolignan recovery, and formulation can influence exposure.

A measured constituent percentage alone cannot show that two finished products have identical performance.

Allergy is relevant, particularly in susceptible people sensitive to related Asteraceae plants.

Memory key: Milk thistle = fruit + Asteraceae + silymarin flavonolignans. Learn the mixture name before memorising its individual components.

5.6 Kutki: hepatoprotective agent

Biological source and family

Kutki consists of dried rhizomes and roots of Picrorhiza kurrooa Royle.

The spelling Picrorhiza kurroa is widely used in pharmacognosy texts.

Its current family is Plantaginaceae; older texts place it in Scrophulariaceae.

Identification

Kutki is a Himalayan perennial with a creeping underground axis, fibrous roots and serrated leaves.

The medicinal rhizome is slender, cylindrical and marked by nodes and scars.

Rootlets arise from the underground axis.

The material is characteristically bitter, but tasting an unknown sample is not an authentication method.

Major constituents

The main teaching constituents are iridoid glycosides, especially picroside I and picroside II.

Kutkin is the traditional name for a glycosidic fraction or mixture associated with these constituents; it should not be described as one universally defined pure compound.

Uses and pharmacological basis

Kutki is traditionally used for liver-related complaints and as a bitter drug.

Hepatoprotective and bile-related effects have been studied experimentally.

These findings do not establish a general clinical cure for hepatitis, jaundice or other liver diseases.

Bitter action and liver-related use are separate aspects of its pharmacognostic profile.

Kutki is the larger plant at right, with serrated leaves, a terminal flower raceme and an underground axis bearing roots. The separate herb at left is not the Kutki drug source.

Diagram labels: Serrated leaf; flower raceme; underground axis; attached roots. Kutki is the plant at right.

Quality and conservation

Rhizome identity, microscopic characters, chemical profile and freedom from substitute underground material are important.

Removal of underground organs can damage wild populations.

Cultivation and regulated collection are therefore important quality and supply considerations.

Powdered material requires stronger authentication than bitterness alone.

Compare: Milk thistle supplies fruits containing flavonolignans; Kutki supplies rhizomes and roots containing iridoid glycosides. Both appear under hepatoprotectives, but their chemistry is different.

5.7 Garlic: cardiovascular agent

Biological source and family

Garlic consists of bulbs of Allium sativum L., family Amaryllidaceae.

Older pharmaceutical classifications often use Liliaceae.

A bulb is a specialised shoot system, not a root.

Identification

The compound bulb has a papery outer covering and several cloves arranged around a basal plate.

Each clove has its own covering and storage tissue associated with a bud.

Fibrous roots arise from the basal region.

Linear foliage and the characteristic odour after crushing support recognition.

Garlic has linear foliage and a bulb formed from storage tissues around a shortened stem. The lower inset section distinguishes the clove arrangement from the whole bulb.

Diagram labels: Linear leaf; flowering head; whole bulb; bulb section.

Major constituents and processing

Intact tissue contains alliin, a sulfur-containing precursor.

Crushing allows alliinase to act on its substrate, initiating formation of allicin, a reactive thiosulfinate.

Allicin is unstable and forms further sulfur compounds, including ajoene under suitable conditions.

Aged garlic extracts may be characterised by S-allylcysteine; this profile is different from freshly crushed garlic.

Uses and pharmacological basis

Garlic preparations have been studied for modest effects on blood pressure and blood lipids.

Results depend on preparation and study context.

Antiplatelet and antimicrobial activities are also investigated.

Garlic is not a replacement for treatment of cardiovascular disease, and the syllabus category does not imply that every garlic formulation has the same effect.

Quality and precautions

Processing can inactivate alliinase or alter sulfur-compound formation.

A label stating only “garlic extract” leaves important compositional questions unanswered.

Odour, gastrointestinal effects and interaction or bleeding concerns are relevant, especially with medicines affecting haemostasis.

Reaction principle: Alliin + active alliinase after tissue disruption → initial reaction products → allicin.

The process is enzymatic and condition-dependent; intact cloves do not simply store a constant large amount of allicin.

5.8 Arjuna: cardiovascular agent

Biological source and family

Arjuna consists of dried stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn., family Combretaceae.

The bark, rather than a leaf or fruit, is the principal medicinal material in this profile.

Identification

The source is a large tree.

Bark pieces are flat or curved, with a relatively smooth greyish external surface in suitable material and a pinkish to reddish-brown inner surface.

Thickness, fracture and surface characters vary with age and collection.

Bark identification requires attention to both outer and inner faces.

Major constituents

Important constituents include triterpenoids, such as arjunic acid and arjunolic acid, together with tannins and flavonoids.

Multiple chemical classes are present.

The acids are triterpenoid constituents; they are not the same substances as garlic’s sulfur compounds.

Uses and pharmacological basis

Arjuna has traditional cardiovascular use, particularly in heart-related Ayurvedic practice.

Cardioprotective, antioxidant and other effects have been investigated, and some preparations have been studied clinically.

The evidence is preparation-specific; the word cardiotonic should not imply treatment of an acute cardiac event or replacement of established cardiovascular medicines.

Arjuna stem-bark specimen with a curved edge, grey outer surface and exposed inner fibrous face. Longitudinal striations support examination of bark morphology.

Diagram labels: Outer bark surface; inner fibrous face; curved bark edge; longitudinal striations.

Quality and collection

Confirm the botanical source and stem-bark identity, examine diagnostic morphology and microscopy, and use a suitable chemical profile.

Excessive or ring-like bark removal can injure or kill a tree.

Controlled collection should preserve the living cambium sufficiently for regeneration and avoid unrestricted girdling.

Memory key: Arjuna = stem bark + Combretaceae + triterpenoid acids/tannins + cardiovascular use. In an answer, specify stem bark rather than writing only “the plant”.

5.9 Gymnema: antidiabetic agent

Biological source and family

Gymnema or gurmar consists of dried leaves of Gymnema sylvestre (Retz.) R.Br. ex Sm., family Apocynaceae.

Older texts use the former family Asclepiadaceae.

Identification

The source is a woody climber.

Leaves are opposite, simple and generally elliptic to ovate with entire margins and conspicuous pinnate venation.

An opposite pair consists of two leaves arising at one node; it is not a compound leaf.

Gymnema leafy shoot with opposite simple leaves, entire margins and finely reticulate pinnate venation. Its climbing stem bears distinct paired nodes.

Diagram labels: Opposite leaves; entire margin; pinnate venation; woody climbing axis.

Major constituents

Gymnemic acids are a group of triterpenoid saponins.

Related saponins and other constituents occur.

Gurmarin is a peptide associated with taste-related research; it is not a gymnemic acid.

A mixture designation should not be mistaken for one compound with a fixed universal composition.

Uses and pharmacological basis

Gymnema is traditionally used in glucose-related disorders.

Its components have been investigated for effects on sweet-taste perception, intestinal glucose handling and other glucose-related pathways.

Some clinical studies examine adjunctive use, but results depend on the preparation.

Suppressing sweetness is an observable taste effect, not proof that the material cures diabetes.

Quality and relevant precautions

Leaf identity and a suitable saponin profile help distinguish authentic material from substitutes.

Extract specifications and marker methods are important because total-saponin measurements are not automatically equivalent to a defined gymnemic-acid assay.

Additive glucose-lowering effects with antidiabetic medicines are a relevant concern.

Memory key: Gymnema = leaf + gymnemic acids + glucose-related use. “Gurmar” helps recall sweet-taste suppression; do not replace the botanical source with the vernacular name alone.

5.10 Fenugreek: antidiabetic agent

Biological source and family

Fenugreek or methi consists of dried ripe seeds of Trigonella foenum-graecum L., family Fabaceae.

The edible leaves are different material from the seed drug specified here.

Identification

The plant is an annual herb with trifoliate leaves and elongated pods.

Seeds are hard, yellowish to brown, angular and often rhomboidal.

A conspicuous groove divides the seed surface obliquely.

On hydration, the mucilaginous fraction swells.

Major constituents

Seeds contain galactomannan-rich mucilage, trigonelline, 4-hydroxyisoleucine and steroidal saponins, along with protein and fixed oil.

Diosgenin can be obtained from suitable steroidal-saponin material after hydrolysis; it should not be presented as the dominant freely available seed constituent.

Uses and pharmacological basis

Fenugreek seeds are used traditionally as a nutritive and digestive material and are studied for glucose and lipid-related effects.

Soluble fibre can modify intestinal handling of nutrients.

Other constituents have experimental effects on glucose regulation.

Clinical effects depend on the amount and preparation; culinary use is not identical to a medicinal extract.

Fenugreek has trifoliate leaves and elongated pods. Enlarged seeds and a seed section are shown separately at right; seeds are the medicinal material.

Diagram labels: Trifoliate leaf; flower; slender pod; enlarged seed.

Quality and precautions

Seed shape, groove, microscopy, swelling behaviour and chemical profile support authentication.

Mucilage-rich powder is susceptible to moisture-related deterioration.

Gastrointestinal effects, allergy in susceptible individuals and additive effects with glucose-lowering medicines are relevant.

Therapeutic use in pregnancy requires particular caution rather than assumptions based on food use.

Compare: Gymnema uses leaves and triterpenoid saponins; Fenugreek uses seeds containing mucilage, alkaloid and steroidal-saponin constituents. Both are antidiabetic teaching examples, but their principal organs and mechanisms differ.

5.11 Turmeric: anti-inflammatory and analgesic agent

Biological source and family

Turmeric consists of rhizomes of Curcuma longa L., family Zingiberaceae.

Commercial material is commonly cured and dried.

A rhizome is an underground stem with nodes, buds and branching; it is not a root.

Identification

Rhizomes include a main body and finger-like branches.

The outer surface bears rings or scars; the cut surface is yellow to orange.

Slender roots may be attached before processing.

The characteristic colour is useful but can be imitated by colouring agents.

Turmeric botanical structures include the large leaf, flowering spike, underground rhizome and attached slender roots. Rhizome stem tissue is distinct from the roots.

Diagram labels: Leaf blade; flowering spike; rhizome axis; attached roots.

Major constituents

Curcuminoids include curcumin, demethoxycurcumin and bisdemethoxycurcumin.

The volatile oil contains turmerones and other terpenoid constituents.

Curcumin belongs to the polyphenolic diarylheptanoid group; turmerones belong to a different fraction.

Uses and pharmacological basis

Turmeric is used traditionally for inflammation-related complaints and in topical or digestive preparations.

Curcuminoids affect several inflammatory signalling pathways in experimental systems.

Some specific preparations have been studied for symptoms such as joint discomfort, but efficacy and exposure vary.

Laboratory activity alone cannot support claims of broad disease treatment.

Preparation and quality

Curcumin has limited aqueous solubility, and absorption depends on formulation.

Whole rhizome powder, oil and a concentrated curcuminoid extract differ.

Authentication includes rhizome characters and suitable chemical tests; colour alone does not establish purity.

Added synthetic colour or other adulterants must be excluded.

Relevant precautions

Gastrointestinal effects and medicine interactions depend on preparation.

Concentrated or enhanced-absorption products should not be treated as identical to ordinary food use.

Reports of liver injury with some supplements are a relevant safety signal.

Memory key: Turmeric = rhizome + curcuminoids + turmerone-containing oil. Write both major fractions when asked for constituents.

5.12 Boswellia: anti-inflammatory and analgesic agent

Biological source and family

Boswellia or Indian frankincense consists of oleo-gum-resin obtained from Boswellia serrata Roxb. ex Colebr., family Burseraceae.

It is an exudate rather than an organised root, bark or leaf drug.

Identification

The collected material occurs as irregular tears or masses, pale yellow to amber or brownish, with a characteristic resinous odour.

It contains a resinous fraction, gum and volatile material.

Appearance varies with collection, drying and storage.

Major constituents

The resin fraction contains boswellic acids, which are pentacyclic triterpenoids.

Important examples include beta-boswellic acid and acetyl-11-keto-beta-boswellic acid (AKBA).

Volatile oil contains other constituents.

Boswellic acids are not volatile-oil components, so distilled frankincense oil is not equivalent to a boswellic-acid extract.

Boswellia serrata botanical features include compound leaves, flowers and fruits. The oleo-gum-resin drug is a collected exudate, rather than these organised plant organs.

Diagram labels: Compound leaf; leaflet venation; flower cluster; fruit sections.

Uses and pharmacological basis

Boswellia extracts are used or studied for inflammatory symptoms, particularly joint-related complaints.

Effects on inflammatory mediator pathways, including leukotriene-related pathways for some constituents, have been investigated.

The activity of one isolated acid cannot be assumed to describe every resin preparation.

Analgesic benefit may accompany reduced inflammatory symptoms without implying a universal painkiller action.

Quality and preparation points

Identity of the source resin, foreign matter, fraction composition and an appropriate chromatographic assay are important.

A total-acid value is not necessarily a specific AKBA measurement.

Extract solvent and enrichment change the final profile.

Gastrointestinal intolerance and product interactions deserve consideration.

Sustainable supply

Tapping should avoid repeated severe injury and allow recovery.

Resin collection is not the same as stripping a complete ring of bark from the trunk.

Compare: Turmeric is an organised rhizome drug; Boswellia is an unorganised oleo-gum-resin drug. Their common syllabus use does not imply common chemistry.

5.13 Brahmi: CNS agent

Biological source and family

Brahmi in this profile is Bacopa monnieri (L.) Wettst., family Plantaginaceae, formerly placed in Scrophulariaceae.

The medicinal material is the whole herb or specified aerial parts, according to the applicable preparation.

Identification

Bacopa is a creeping succulent herb, often associated with moist places.

Leaves are opposite, small, fleshy, obovate to oblong and usually short-stalked or sessile.

Roots can arise at nodes.

Flowers are small, whitish or pale bluish.

Correct species identification is essential because the common name Brahmi is also used for another plant.

Bacopa monnieri has creeping shoots, opposite fleshy leaves and small flowers. These structures distinguish it from long-petioled, round-leaved Centella.

Diagram labels: Fleshy leaf; small flower; creeping stem; opposite leaves.

Major constituents

Bacosides are a group of triterpenoid saponins.

Bacoside A represents a mixture of related saponins rather than one universally defined pure molecule.

Other saponins and minor constituents contribute to the herb’s chemical profile.

Uses and pharmacological basis

Bacopa is traditionally used as a medhya rasayana, associated with learning and memory.

Standardised extracts have been studied for certain cognitive outcomes.

Proposed effects on neuronal signalling, oxidative processes and other pathways are investigated experimentally.

It is not an immediate intelligence enhancer, and evidence does not establish treatment of every neurological disease.

Distinguish Bacopa from Centella

Centella asiatica, often called gotu kola or mandukaparni and sometimes Brahmi, is a different species in Apiaceae.

Its long-petioled rounded or kidney-shaped leaves differ from Bacopa’s opposite fleshy leaves.

Centella is associated with asiaticoside and related triterpenoids; these should not replace bacosides in a Bacopa answer.

Quality and precautions

Authenticate the species and stated organ before assaying markers.

Gastrointestinal effects are relevant for oral preparations.

Moist-habitat collection requires care about microbial and other contamination.

Memory key: Bacopa Brahmi = opposite succulent leaves + bacosides + cognition-related use.

5.14 Giloy: antimicrobial and antiviral teaching group

Biological source and family

Giloy or Guduchi is commonly obtained from mature stems of Tinospora cordifolia (Willd.) Hook.f. & Thomson, family Menispermaceae.

Other organs occur in research and traditional contexts, but the specified stem should be identified in this drug profile.

Identification

The plant is a climber with alternate, heart-shaped leaves and prominent veins radiating from near the leaf base.

Mature stems are cylindrical, often corky or warty, and may produce aerial roots.

Stem pieces must not be authenticated solely from a photograph of the leaf.

Giloy climbing shoot with heart-shaped leaves, radiating veins and distinct petioles. The leaf supports botanical recognition; mature stem is the principal drug material in this profile.

Diagram labels: Heart-shaped blade; radiating veins; climbing stem; leaf stalk.

Major constituents

The plant contains diterpenoid lactones and glycosides, alkaloids and polysaccharides.

Frequently discussed marker-related constituents include tinosporaside and magnoflorine.

Constituents differ by organ and preparation; one marker does not represent the complete stem chemistry.

Uses and pharmacological basis

Giloy is used in traditional practice for fever-related complaints and as a rasayana.

Immunomodulatory, antimicrobial and antiviral activities are investigated in experimental settings.

Placement in this syllabus group does not establish clinical prevention or treatment of a particular viral infection.

A necessary distinction

An immunomodulatory agent changes immune responses; it does not simply strengthen all immune activity.

More immune activation can be undesirable in some situations.

Traditional hepatoprotective claims must also be distinguished from evidence about product-associated liver injury.

Quality and relevant precautions

Authenticate T. cordifolia and exclude other Tinospora species or substituted stems.

Microscopy and suitable chemical profiling supplement macroscopic inspection.

Liver injury has been reported with Giloy use, including clinically documented cases; therefore it must not be labelled universally harmless or protective for every liver condition.

Memory key: Giloy = mature stem + Menispermaceae + mixed diterpenoid/alkaloid/polysaccharide chemistry. Avoid writing “proven antiviral cure”.

5.15 Neem: antimicrobial and antiviral teaching group

Biological source and family

Neem is obtained from Azadirachta indica A.Juss., family Meliaceae.

Leaves, bark, seeds and seed oil are used in different contexts.

A medicinal description must identify which organ or preparation is intended.

Identification

Neem has pinnately compound leaves with multiple toothed leaflets.

Leaflets are often somewhat asymmetric at the base.

Flowers are small and pale, and the fruit is drupe-like.

A leaflet is not the entire compound leaf.

Major constituents

Important chemical groups include limonoids, with examples such as nimbin, nimbolide and azadirachtin in relevant organs.

Seed preparations have their own profile.

Nimbidin refers to a chemically complex fraction associated with seed-oil investigations, rather than a universal single marker for every neem product.

Uses and pharmacological basis

Neem is used traditionally in skin, oral-hygiene and other preparations.

Antimicrobial and antiviral effects are largely reported in experimental systems, while some specific topical or oral-hygiene products have been studied clinically.

Azadirachtin is well known for insect-related activity; that role should not be confused with proof of clinical antiviral efficacy.

Organ-specific quality

A leaf extract, bark preparation and seed oil differ chemically and physically.

Authentication begins with the organ.

Suitable microscopy, chromatographic profile, contamination testing and oil-quality measurements depend on the material.

Strong bitterness or green colour cannot confirm identity or suitability.

Neem branch with pinnately compound leaves, individual toothed leaflets, flowers and enlarged fruit details. A leaflet must not be mistaken for the complete leaf.

Diagram labels: Toothed leaflet; flower cluster; compound leaf axis; fruit.

Relevant precautions

Concentrated seed oil is not simply a food-like preparation.

Ingestion can be hazardous, particularly in children, and exposure route matters.

Pregnancy-related use and claims of internal infection treatment require particular care.

Topical use also requires assessment of irritation and product quality.

Memory key: Neem = Meliaceae + compound leaves + organ-dependent limonoids. State the preparation before assigning a use.

5.16 Andrographis: antimicrobial and antiviral teaching group

Biological source and family

Andrographis or Kalmegh consists of dried aerial parts, particularly leaves, of Andrographis paniculata (Burm.f.) Nees, family Acanthaceae.

It is characteristically bitter.

Identification

The source is an erect herb with opposite, narrow to lanceolate leaves having entire margins.

Stems are commonly quadrangular.

Small flowers occur in branched inflorescences and have a pale corolla with characteristic markings.

Slender capsules contain seeds.

Andrographis aerial shoot with opposite narrow leaves, small marked flowers and a longitudinally seamed capsule. The leaf margins are entire.

Diagram labels: Small marked corolla; capsule seam; opposite narrow leaves; stem node.

Major constituents

Andrographolide is an important diterpenoid lactone.

Related compounds include neoandrographolide and deoxyandrographolide derivatives.

These are not quinazoline alkaloids; the latter are associated with Vasaka.

Uses and pharmacological basis

Kalmegh is traditionally used for fever and digestive or liver-related complaints.

Antimicrobial, antiviral and anti-inflammatory actions have been examined experimentally.

Some specified preparations have been studied for symptoms of uncomplicated respiratory infections.

Symptom studies do not establish eradication of a virus, prevention of severe disease or equivalence between all extracts.

Quality and preparation points

Aerial-part identity, leaf morphology and andrographolide-related chemical profiling are important.

A bitterness test cannot distinguish all substitute herbs.

Processing, extraction and assay methodology affect the measured profile.

Whole herb and a concentrated diterpenoid preparation are different materials.

Relevant precautions

Allergic reactions, including severe reactions, are an important concern.

A herbal origin does not prevent allergy.

Gastrointestinal effects and medicine interactions may also matter.

Do not describe concentrated preparations as automatically safe because the plant has traditional use.

Compare: Andrographis and Vasaka are both in Acanthaceae, but Andrographis → diterpenoid lactones, whereas Vasaka → quinazoline alkaloids. This is a useful examination distinction.

5.17 Psyllium: gastrointestinal agent

Biological source and family

Psyllium or isabgol is obtained from seeds of Plantago ovata Forssk., family Plantaginaceae.

The seed husk is the separated outer seed covering and is a distinct commercial material from the whole seed.

Identification

The plant has narrow basal leaves and leafless stalks bearing compact flower spikes.

Seeds are small, pale to brownish and boat-shaped, with a characteristic concave face.

Husk occurs as light flakes.

Whole seed includes tissues not present in separated husk.

Major constituents

The principal functional material is hydrophilic mucilage, rich in arabinoxylan-type polysaccharides.

Its water uptake and gel-forming properties are central to the medicinal effect.

It is not an anthraquinone stimulant laxative.

Uses and mechanism

Psyllium is a bulk-forming laxative.

On sufficient hydration, mucilage increases the water-holding capacity and bulk of intestinal contents, supporting stool passage.

Selected preparations also have use in dietary-fibre management and have been studied for lipid or glucose-related effects.

These additional uses do not change its principal gastrointestinal classification.

Plantago ovata bears narrow basal leaves and leafless spike-bearing stalks. The enlarged seed shows the concave face and outer coat from which the husk is separated.

Diagram labels: Dense flower spike; concave seed face; narrow basal leaves; seed coat/husk.

Preparation and quality

Swelling behaviour, identity, purity, microbial quality and particle characteristics are important.

Swelling index expresses the volume occupied by a specified mass after hydration under defined test conditions.

Conditions and material must be stated; the index is not a universal constant for every batch.

Relevant precautions

Adequate fluid is essential.

Dry ingestion or inappropriate use in a person with swallowing difficulty or suspected bowel obstruction can be hazardous.

Timing relative to other medicines may matter because fibre can alter their absorption.

Bulk-forming action should not be mistaken for rapid stimulant action.

Memory key: Psyllium = seed/husk + mucilage + hydration-dependent bulk formation.

5.18 Aloe: dermatological agent

Biological source and family

Aloe gel is obtained from the inner leaf tissue of Aloe vera (L.) Burm.f., synonym Aloe barbadensis Mill., family Asphodelaceae.

Older texts often use Liliaceae.

Gel, latex and whole-leaf extract are different materials.

Identification and leaf anatomy

Aloe has a rosette of thick, fleshy, tapering leaves with toothed margins.

The outer rind surrounds water-rich inner parenchyma.

Vascular bundles and latex-associated tissues occur toward the leaf periphery.

The clear central gel should be distinguished from the yellow bitter latex released near the rind.

Aloe leaf transverse section with rind, gel parenchyma and peripheral vascular bundles associated with the latex region. Clear inner gel and yellow latex are different fractions.

Diagram labels: Rind/chlorenchyma; peripheral latex region; gel parenchyma cells; vascular bundle. Inner gel is distinct from yellow latex.

Major constituents

The gel contains water and polysaccharides, including acemannan, an acetylated mannan.

The latex contains hydroxyanthracene derivatives, including aloin/barbaloin.

Assigning aloin as the principal desired constituent of purified inner-leaf gel confuses two different products.

Uses and pharmacological basis

Suitable aloe gel preparations are used topically for moisturising and soothing skin.

Some skin and wound-related outcomes have been studied, with benefit depending on the condition and preparation.

Gel is not a general cure for every burn or skin disease.

Latex has historically been used as a stimulant laxative; this is a separate use and carries important safety limitations.

Processing and quality

Separation of rind and latex from inner gel helps control unwanted anthracene derivatives.

Fresh gel can deteriorate microbiologically and chemically; suitable stabilisation, hygiene and preservation are needed.

Identity, polysaccharide quality and appropriate contaminant limits matter more than the word “aloe” on a label.

Essential distinction: Inner gel → polysaccharides → dermatological preparations. Yellow latex → aloin-related compounds → stimulant-laxative history. Neither fraction should be substituted for the other.

5.19 Chasteberry: women’s-health agent

Biological source and family

Chasteberry consists of dried ripe fruits of Vitex agnus-castus L., family Lamiaceae; older texts place it in Verbenaceae.

It is not the same plant as every other medicinal species of Vitex.

Identification

The source is a shrub or small tree with palmately compound leaves, commonly bearing five to seven narrow leaflets.

Flowers occur in terminal inflorescences.

Fruits are small, nearly globular and dark on drying, with a persistent calyx at the base.

Major constituents

Important constituents include iridoid glycosides, such as agnuside and aucubin, the flavonoid casticin, and diterpenoid constituents.

Marker choice depends on the product specification.

A marker is not necessarily the sole active component.

Uses and pharmacological basis

Defined chasteberry preparations are used for premenstrual syndrome (PMS) or related menstrual symptoms.

Dopaminergic effects and modulation of prolactin release have been investigated for relevant constituents and preparations.

The phrase “hormone balancing” is too vague to explain the pharmacology accurately.

Chasteberry flowering branch with palmately compound leaves. The small enlarged detail at right shows the fruit in section; ripe fruits supply the medicinal drug.

Diagram labels: Palmate leaf; flower spike; main stem; fruit section.

Evidence and limitations

Clinical evidence concerns particular extracts and symptom outcomes.

It does not establish a general fertility treatment, a pregnancy-support agent or a cure for every menstrual disorder.

Hormonal conditions and concomitant treatments can affect suitability.

Quality and precautions

Fruit identity, organ purity and an appropriate chromatographic profile are essential.

Interaction concerns include medicines acting on dopamine-related or hormonal pathways.

Pregnancy and breastfeeding use should not be inferred from its women’s-health category.

The category refers to a defined application, not universal suitability for all women.

Memory key: Chasteberry = Vitex fruit + agnuside/casticin + PMS-related use. A palmately compound leaf differs from Neem’s pinnately compound leaf.

5.20 Shatavari: women’s-health agent

Biological source and family

Shatavari consists of tuberous roots of Asparagus racemosus Willd., family Asparagaceae.

Older pharmaceutical texts often place the plant in Liliaceae.

Identification

The source is a climbing or scrambling plant with slender photosynthetic cladodes and small scale-like true leaves.

Cladodes are modified stems, not ordinary needle leaves.

The underground system bears clusters of elongated fleshy tuberous roots.

A tuberous root lacks the stem nodes and buds of a rhizome.

Shatavari aerial branch with cladode clusters, spines and flower racemes. Cladodes are modified stems; the medicinal material consists of underground tuberous roots.

Diagram labels: Flower raceme; cladode cluster; stem spine; aerial branch.

Major constituents

The root contains steroidal saponins, particularly the shatavarins, along with other constituents.

The chemical class differs from Bacopa’s and Gymnema’s predominantly triterpenoid-saponin teaching profiles.

Uses and pharmacological basis

Shatavari is traditionally used as a nutritive restorative in women’s-health practice and as a galactagogue, a term describing promotion of milk secretion.

Reproductive and lactation-related effects have been investigated, but the clinical evidence is limited and preparation-dependent.

Traditional use does not guarantee increased milk supply or fertility.

Quality and preparation points

The tuberous root must be distinguished from roots of other Asparagus species and from substituted fleshy underground organs.

Macroscopic and microscopic features, saponin profile, moisture and contamination checks support quality.

The above-ground cladodes are not substitutes for the prescribed root drug.

Relevant precautions

Allergy is possible, including in susceptible people with related plant sensitivity.

Pregnancy, hormonal conditions and breastfeeding-related use require assessment of the actual preparation rather than assuming that the women’s-health category proves safety.

Compare: Shatavari = tuberous root + steroidal saponins + traditional restorative/galactagogue use. Chasteberry = fruit + iridoid/flavonoid markers + PMS-related use.

5.21 Vasaka: respiratory agent

Biological source and family

Vasaka consists principally of leaves of Justicia adhatoda L., synonym Adhatoda vasica Nees, family Acanthaceae.

The synonym is common in examination texts.

Identification

The source is a shrub with opposite, elongated elliptic to lanceolate leaves, entire margins and conspicuous pinnate venation.

Flowers are pale or white, bilabiate and marked with purple lines, occurring in dense bracted clusters.

Leaf size and venation support recognition but do not alone confirm a powdered sample.

Major constituents

Vasicine and vasicinone are important quinazoline alkaloids.

Additional related alkaloids occur.

The relationship between processing conditions and alkaloid profile matters; the constituents should not be confused with Andrographis diterpenoid lactones.

Vasaka flowering shoot with opposite leaves, conspicuous venation and pale bilabiate flowers bearing purple markings.

Diagram labels: Leaf venation; bilabiate flower; opposite leaf base; purple markings.

Uses and pharmacological basis

Vasaka is traditionally used as an expectorant in cough-related preparations.

Alkaloid-containing materials have been investigated for airway-related effects.

Expectorants aid removal of respiratory secretions; they are not identical to cough suppressants.

Experimental bronchodilator activity does not establish that a crude leaf preparation can manage an acute asthma attack.

Quality and preparation points

Identify the correct leaf, examine diagnostic microscopy and assess the relevant alkaloid profile.

Whole leaf, decoction and concentrated extract are different preparations.

Bitterness alone is insufficient to distinguish Vasaka from other bitter herbs.

Moisture and microbial control are important for dried leaves and liquid preparations.

Relevant precautions

Pregnancy-related concerns are relevant because uterine effects have been associated with constituents in experimental work.

Respiratory symptoms should not automatically be attributed to a simple cough; the syllabus use describes pharmacognostic application rather than emergency treatment.

Memory key: Vasaka = leaf + Acanthaceae + vasicine/vasicinone + expectorant use.

5.22 Complete drug-organ-constituent revision map

Drug and medicinal material Major teaching constituents
Ashwagandha: root Withanolides; withanosides
Tulsi: leaves/aerial parts Eugenol-rich variable oil; ursolic and rosmarinic acids
Milk thistle: ripe fruit Silymarin flavonolignans
Kutki: rhizome and roots Picrosides; kutkin fraction
Garlic: bulb Alliin; enzyme-generated allicin and other sulfur compounds
Arjuna: stem bark Arjunic/arjunolic acids; tannins and flavonoids
Gymnema: leaves Gymnemic-acid saponins; gurmarin
Fenugreek: seeds Galactomannan; trigonelline; 4-hydroxyisoleucine; saponins
Turmeric: rhizome Curcuminoids; turmerone-containing oil
Boswellia: oleo-gum-resin Boswellic acids, including AKBA
Brahmi: Bacopa herb Bacoside saponins
Giloy: mature stem Diterpenoids, alkaloids and polysaccharides
Neem: organ-dependent material Limonoids; seed preparations have a distinct profile
Andrographis: aerial parts Andrographolide-related diterpenoid lactones
Psyllium: seed/husk Arabinoxylan-rich mucilage
Aloe: inner gel Acemannan and other polysaccharides
Chasteberry: ripe fruit Agnuside, aucubin, casticin and diterpenoids
Shatavari: tuberous root Shatavarin steroidal saponins
Vasaka: leaf Vasicine and vasicinone

How to use the map

Cover the right column and name a class plus one example.

Then cover the left column and identify the drug and organ.

Finally add the therapeutic category.

This three-way recall prevents answers that correctly name a compound but assign it to the wrong medicinal material.

5.23 Important comparisons

Underground organs

Roots lack stem nodes, internodes and buds.

Ashwagandha is a root drug; Shatavari is a tuberous-root drug.

Rhizomes are underground stems: Turmeric and the rhizome component of Kutki show stem organisation.

Bulbs are shortened shoots with storage leaves or associated fleshy tissues: Garlic is a bulb drug.

Leaf architecture

  • Tulsi, Gymnema, Bacopa, Andrographis and Vasaka: opposite simple leaves.
  • Giloy: alternate heart-shaped simple leaves.
  • Neem: pinnately compound leaves with toothed leaflets.
  • Chasteberry: palmately compound leaves.
  • Shatavari: photosynthetic cladodes, with reduced true leaves.

Chemical distinctions

Easily confused terms Correct distinction
Silymarin and silybin Mixture versus a major flavonolignan component
Alliin and allicin Precursor versus reactive product formed after disruption
Bacosides and asiaticoside Bacopa profile versus Centella profile
Gymnemic acids and shatavarins Triterpenoid versus steroidal-saponin groups
Aloe gel and latex Polysaccharide-rich inner gel versus anthracene-containing latex
Andrographolide and vasicine Diterpenoid lactone versus quinazoline alkaloid
Mucilage and resin Hydrophilic swelling polysaccharides versus predominantly resinous material

Therapeutic distinctions

Bulk-forming laxative: hydrated Psyllium modifies stool bulk and water retention.

Stimulant-laxative history: Aloe latex involves a different fraction and mechanism.

Expectorant: Vasaka is associated with secretion clearance.

Analgesic: relief of pain; an anti-inflammatory mechanism can contribute but is not synonymous with every analgesic mechanism.

5.24 Quality, processing and standardisation

Step 1: confirm identity

Check the accepted botanical source, relevant synonym, family and organ.

Use macroscopic and microscopic examination where appropriate.

A shared common name is not enough, especially for Brahmi.

Step 2: confirm purity

Assess foreign matter, moisture, microbial contamination, pesticide residues and elemental contaminants according to the applicable specification.

Reject substituted organs and undeclared colouring or enrichment.

A high marker percentage cannot compensate for the wrong species.

Step 3: characterise composition

Use suitable chromatographic profiles and validated marker assays.

Distinguish total extractives, total class assays and specific-compound assays.

Boswellia total acids and AKBA content are different quantities; silymarin and silybin are different reporting targets.

Step 4: control processing

Protect volatile fractions in Tulsi and Turmeric from inappropriate storage or heating.

Control alliinase-related processing in Garlic.

Separate Aloe inner gel from the latex-containing peripheral region.

Dry moisture-sensitive seed and herb material appropriately and prevent contamination.

Step 5: describe the finished preparation

State the starting organ, solvent system, extraction ratio when defined, marker specification and dosage form.

Do not transfer evidence from one preparation to an unrelated product.

A batch’s consistency and its clinical efficacy require different kinds of assessment.

Worked example: marker amount

Hypothetical arithmetic only.

An extract mass m is 200 mg and its specified marker content p is 5% by mass.

Marker mass M = m × p/100 = 200 × 5/100 = 10 mg

Here m and M are in mg; p is the numerical percentage.

This calculates marker content, not a therapeutic dose or proof of efficacy.

Worked example: swelling index

Under one defined classroom test, 1.0 g of husk occupies 18 mL after hydration.

Index = hydrated volume/starting mass = 18/1.0 = 18 mL/g

Material, time, liquid and measurement method must match before comparing batches.

The result is hypothetical, not an acceptance limit.

5.25 Final revision and examination practice

Ten groups in one recall chain

  • Adaptogens: Ashwagandha, Tulsi.
  • Hepatoprotectives: Milk thistle, Kutki.
  • Cardiovascular: Garlic, Arjuna.
  • Antidiabetics: Gymnema, Fenugreek.
  • Anti-inflammatory/analgesic: Turmeric, Boswellia.
  • CNS: Brahmi.
  • Antimicrobial/antiviral: Giloy, Neem, Andrographis.
  • GI: Psyllium.
  • Skin: Aloe.
  • Women’s health: Chasteberry, Shatavari.
  • Respiratory: Vasaka.

Common errors to avoid

  • Calling Turmeric a root or Garlic a root.
  • Calling Milk thistle fruit a leaf drug.
  • Describing silymarin or bacoside A as one pure compound.
  • Assigning aloin as the main desired marker of inner Aloe gel.
  • Confusing Bacopa with Centella.
  • Drawing Neem as a single simple leaf.
  • Calling Shatavari cladodes ordinary true leaves.
  • Treating laboratory antiviral activity as an established clinical cure.

One-minute recall

Name one root, rhizome, bulb, bark, leaf, fruit, seed and unorganised drug from this unit.

Then attach its constituent class and syllabus use.

Short-answer questions

  • Define phytotherapy and distinguish a crude drug from an extract.
  • State the source, family and constituents of Ashwagandha.
  • Explain alliin-to-allicin formation in Garlic.
  • Distinguish Aloe gel from Aloe latex.
  • Why is Psyllium called a bulk-forming laxative?
  • Compare Bacopa Brahmi with Centella.
  • Name the major alkaloids of Vasaka.

Long-answer questions

  • Give comparative pharmacognostic accounts of Milk thistle and Kutki.
  • Compare Gymnema and Fenugreek: source, organ, constituents and uses.
  • Describe Turmeric and Boswellia, including differences in drug type.
  • Write accounts of all three drugs in the antimicrobial/antiviral group, distinguishing studied activity from established clinical use.
  • Explain the women’s-health drugs with their sources and major constituents.

Answer-writing checklist

Source → family → medicinal part → identification → major constituents → uses → important distinction.

Add a relevant labelled sketch and avoid unsupported claims.

An accurate concise answer is stronger than an unqualified list of activities.

Exclusive Student Alerts

Join AKTU VIP Telegram & WhatsApp Group

Get immediate exam updates, syllabus changes, quantum PDFs, and viva questions.

Have Questions or Want to Discuss?

Join the community conversation or ask your queries in the comments.

View Comments & Discussion →
Home Notes Syllabus PYQs Quantum